UBI included in LifeScan Briefing

15 Jun 2010

Universal Biosensors, Inc. (ASX: UBI) announced today that LifeScan, Inc had provided information concerning its strategic intentions for Its OneTouch® Verio™ product developed with UBI. This occurred during the Diabetes Care Franchise Review, which was part of the Johnson & Johnson Medical Devices and Diagnostics Business Review with analysts.

Read the full report

All News